Increased expression of ALCAM/CD166 in pancreatic cancer is an independent prognostic marker for poor survival and early tumour relapse

Authors

Keywords

Journal

Volume 101, Issue 3, Pages 457-464

Publisher

Springer Nature

Online

2009-07-15

DOI

10.1038/sj.bjc.6605136

References

View 4 related references

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now